₹ 556.15
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Coral Laboratories Ltd. specializes in the production of various pharmaceutical drug formulations. The company's operations are segmented geographically across Ethiopia, India, and other international territories. Its comprehensive product line encompasses solid dosage forms like tablets and capsules, liquid medications, topical treatments, ophthalmic and otic solutions, and injectable preparations. Founded on June 19, 1981, the firm's main corporate office is located in Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT
Data is available to registered users only